6QG-22262-93875
3 vaccinations
3 coded responses
24 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 641 / MO
- Registered
- 2021-01-04
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-04
Registered in v-safe
-
2021-01-04
Dose 1 — Moderna
- 2021-01-04
- 2021-01-05
- 2021-01-09
- 2021-01-10
- 2021-01-11
-
2021-01-18
Survey response — day 14, dose 1MedDRA: Injection site rash — Feeling: GoodFree text: Rash around injection site on 1/16. Went away after icing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
-
2021-02-01
Dose 2 — Moderna
- 2021-02-01
- 2021-02-02
-
2021-02-04
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-02-06
- 2021-02-08
- 2021-08-04
-
2021-10-28
Dose 3 — Moderna
- 2021-10-28
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · HeadacheAdult check-in
-
2021-11-11
Survey response — day 14, dose 3MedDRA: Headache — Feeling: FairFree text: HeadacheMedDRA releases: 2024-11 · check-in free text available
- 2021-11-20
- 2021-11-25
- 2021-12-04
- 2021-12-09
- 2022-01-29
-
2022-04-30
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: ColdMedDRA releases: 2024-11 · check-in free text available
-
2022-04-30
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-05-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-04 | Moderna | |
| 2 | 2021-02-01 | Moderna | |
| 3 | 2021-10-28 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-30 | Unsuccessful |
Free text
Release 2 — day 14, dose 1
Symptoms: Rash around injection site on 1/16. Went away after icing.
Release 10 — day 14, dose 3
Symptoms: Headache
Release 11 — 6 months, dose 3
Symptoms: Cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release